1. A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3. Issue 1 (24th June 2021) Authors: Halatsch, Marc-Eric; Kast, Richard E; Karpel-Massler, Georg; Mayer, Benjamin; Zolk, Oliver; Schmitz, Bernd; Scheuerle, Angelika; Maier, Ludwig; Bullinger, Lars; Mayer-Steinacker, Regine; Schmidt, Carl; Zeiler, Katharina; Elshaer, Ziad; Panther, Patricia; Schmelzle, Birgit; Hallmen, Anke; Dwucet, ... Journal: Neuro-oncology advances Issue: Volume 3:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bcl‐2/Bcl‐xL inhibition predominantly synergistically enhances the anti‐neoplastic activity of a low‐dose CUSP9 repurposed drug regime against glioblastoma. (30th July 2019) Authors: Halatsch, Marc‐Eric; Kast, Richard Eric; Dwucet, Annika; Hlavac, Michal; Heiland, Tim; Westhoff, Mike‐Andrew; Debatin, Klaus‐Michael; Wirtz, Christian Rainer; Siegelin, Markus David; Karpel‐Massler, Georg Journal: British journal of pharmacology Issue: Volume 176:Number 18(2019) Page Start: 3681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CBMT-35. METABOLIC REWIRING BY ONC201/TIC10 AND 2-DEOXYGLUCOSE HAS SYNERGISTIC ANTI-GLIOBLASTOMA ACTIVITY. (11th November 2019) Authors: Pruss, Maximilian; Dwucet, Annika; Hlavac, Michal; Kast, Richard; Westhoff, Mike-Andrew; Wirtz, Rainer; Halatsch, Marc-Eric; Siegelin, Markus; Karpel-Massler, Georg Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTNI-04. RECURRENT GLIOBLASTOMA LONG-TERM SURVIVORS TREATED WITH CUSP9v3. (12th November 2021) Authors: Halatsch, Marc-Eric; Kast, Richard; Karpel-Massler, Georg; Mayer, Benjamin; Zolk, Oliver; Schmitz, Bernd; Scheuerle, Angelika; Maier, Ludwig; Bullinger, Lars; Mayer-Steinacker, Regine; Schmidt, Carl; Zeiler, Katharina; Elshaer, Ziad; Panther, Patricia; Schmelzle, Birgit; Hallmen, Anke; Dwucet, An... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EXTH-45. THE REPURPOSED CUSP9 REGIMEN EXERTS POTENT ANTI-NEOPLASTIC ACTIVITY AGAINST GLIOBLASTOMA CELLS IN VITRO. (5th November 2018) Authors: Halatsch, Marc-Eric; Kast, Richard Eric; Dwucet, Annika; Siegelin, Markus; Heiland, Tim; Karpel-Massler, Georg Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EXTH-54. Bcl-2/Bcl-xL INHIBITION SYNERGISTICALLY ENHANCES THE ANTI-NEOPLASTIC ACTIVITY OF CUSP9 AGAINST GLIOBLASTOMA CELLS IN VITRO. (5th November 2018) Authors: Halatsch, Marc-Eric; Kast, Richard Eric; Dwucet, Annika; Wirtz, Christian Rainer; Siegelin, Markus; Karpel-Massler, Georg Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EXTH-55. CONCOMITANT INHIBITION OF RAC1 AND Bcl-2/Bcl-xL INTERFERES WITH THE Mcl-1/Usp9X AXIS AND YIELDS SYNERGISTIC ANTI-GLIOMA ACTIVITY. (5th November 2018) Authors: Hlavac, Michal; Dwucet, Annika; Westhoff, Mike-Andrew; Kast, Richard Eric; Engelke, Jens; Siegelin, Markus; Wirtz, Christian Rainer; Halatsch, Marc-Eric; Karpel-Massler, Georg Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. EXTH-68. DUAL METABOLIC REPROGRAMMING BY ONC201/TIC10 AND 2-DEOXYGLUCOSE HAS A STRONG ANTIPROLIFERATIVE EFFECT ON MEDULLOBLASTOMA CELLS. (12th November 2021) Authors: Dwucet, Annika; Cao, Qiyu; Pruss, Maximilian; Westhoff, Mike-Andrew; Wirtz, Christian Rainer; Siegelin, Markus D; Karpel-Massler, Georg Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗